Navigation Links
UCLA scientists transform HIV into cancer-seeking missile

Camouflaging an impotent AIDS virus in new clothes enables it to hunt down metastasized melanoma cells in living mice, reports a UCLA AIDS Institute study in the Feb. 13 online edition of Nature Medicine. The scientists added the protein that makes fireflies glow to the virus in order to track its journey from the bloodstream to new tumors in the animals' lungs.

"For the past 20 years, gene therapy has been hampered by the lack of a good carrier for therapeutic genes that can travel through the blood and aim itself at a precise location, thereby minimizing harmful side effects," explained Irvin S.Y. Chen, Ph.D., director of the UCLA AIDS Institute. "Our approach proves that it is possible to develop an effective carrier and reprogram it to target specific cells in the body."

The UCLA team employed a two-step approach to transform HIV into a cancer-seeking machine. First, the scientists used a version of HIV from which the viral pieces that cause AIDS had been removed. This allowed the virus to infect cells and spread throughout the body without provoking disease.

"The disarmed AIDS virus acts like a Trojan horse ?transporting therapeutic agents to a targeted part of the body, such as the lungs, where tumors often spread," said Chen, a professor of medicine, microbiology, immunology and molecular genetics and a member of the Jonsson Comprehensive Cancer Center at the David Geffen School of Medicine at UCLA.

Second, the scientists stripped off HIV's viral coat and redressed it in the outer suit of the Sindbis virus, which normally infects insects and birds. By altering the Sindbis coat, they reprogrammed the AIDS virus, which ordinarily infects T-cells, to hunt down and attach to P-glycoproteins -- molecules located on the surface of many cancer cells. The UCLA team is the first to prove that modified HIV will target and bind with P-glycoproteins.

"P-glycoproteins cause big problems by making the cell resistant to chemotherapy,"
'"/>

Source:University of California - Los Angeles


Page: 1 2

Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
3. UAB scientists discover the origin of a mysterious physical force
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
6. U-M scientists find genes that control growth of common skin cancer
7. RNA project to create language for scientists worldwide
8. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
9. To control germs, scientists deploy tiny agents provocateurs
10. Leprosy microbes lead scientists to immune discovery
11. Integration of Agilents MS technology, Proteome Systems software to help scientists in proteomics research

Post Your Comments:
(Date:11/19/2009)...A four-year, multi-institutional effort co-led by ...sts culminated today in publication of a landmark ...g in unprecedented detail the DNA sequence of maiz...called by North American consumers, is one of the ...e agricultural crop grown in the United States, re...
(Date:11/19/2009)...searchers at Louisiana Tech University has found t...natural herbicide against giant salvinia. , Gian...that can block all sunlight penetration into bodie...al conditions, it,s been reported that giant salvi.... Lynn Walker, professor of biological sciences at...
(Date:11/19/2009)...ue University scientists have helped identify and ... wall development in maize, an effort that expands...mass best suited for biofuels production. , The ...essor of plant cell biology, published their findi...nt Physiology on Thursday (Nov. 19). They also we...
Breaking Biology News(10 mins):Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Microorganism may provide key to combating giant salvinia throughout Louisiana 2Maize cell wall genes identified, giving boost to biofuel research 2MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 1MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 2MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 3MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 4A Power Energy Generation Systems Ltd Signs a Biomass Based DG Contract with Sanmenxia New Energy Bio Electricity Co Ltd 12639 1A Power Energy Generation Systems Ltd Signs a Biomass Based DG Contract with Sanmenxia New Energy Bio Electricity Co Ltd 12639 2A Power Energy Generation Systems Ltd Signs a Biomass Based DG Contract with Sanmenxia New Energy Bio Electricity Co Ltd 12639 3Free Ask a Doctor Online Services Can Save Lives with Both Expert and Novice Input 48997 1Free Ask a Doctor Online Services Can Save Lives with Both Expert and Novice Input 48997 2Free Ask a Doctor Online Services Can Save Lives with Both Expert and Novice Input 48997 3
...s of cancer continues to pose a major problem for ... forms of chemotherapy or become resistant to the ... Infection Research (HZI) in Braunschweig, the Han...(LUH) in Hanover have now discovered a chemical me... destroys tumours. Today, the researchers publish ...
...of on-the-go crop and soil sensors has greatly inc... their crops. Recently released research in Agron...ment is necessarily more efficient. They discovere...recision agriculture, calculating how large of an ...nt techniques. According to the authors, this chan...
...h . , Barcelona, Spain: Couples who need IVF i...his will not lead to developmental problems in ear...l conference of the European Society of Human Repr.... Karin Middelburg, from the University Medical Ce...hat the study, which looked at the quality of gene...
Other Biology News:Argyrin: Natural substance raises hope for new cancer therapies 2IVF does not increase risk of developmental disorders in children 2
(Date:11/19/2009)..., , COPENHAGEN, Nov. 19 Dani...Inbicon cellulosic ethanol plant in Kalundborg, De...one of the world,s first and largest 2nd generatio...Accellerase enzymes are used in the plant,s innova...r, a Division of Danisco, was the first to market ...
(Date:11/19/2009)..., , NEW YORK, Nov. 19 /PRNewswire-FirstCall...oday that it has sent the following letter to its ..., on October 30, 2009, of China Biopharmaceuticals...utical company based in the People,s Republic of C...nterest in Suzhou Eyre Pharmaceutical Co. Ltd., CH...
(Date:11/19/2009)..., , MONTREAL, Nov. 19 /PRNewswire/ - Aegera...he first patient in a randomized Phase 2B study of...-stage development for multiple oncology indicatio...mized Phase 2 Study of the X-Linked Inhibitor of A...ation with High-dose Cytarabine and Idarubicin in ...
(Date:11/19/2009)..., , VIENNA, Austria, November 19 /P...s vaccine program on one product candidate at an u...e candidate AD02 is planned to enter into,Phase II...e company,immediately follows the completion of tw.... The company based its fast decision on the first...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...E, Md., Dec. 9 EntreMed, Inc.,(Nasdaq: ENMD ), ...,therapeutics for the treatment of cancer and infl...tiated a Phase 1 study of ENMD-2076 in refractory,...cted at the Indiana,University Melvin and Bren S...rif Farag, Associate Professor, Department of Medi...
... Oberon FMR, Inc. was selected a...he recent BioWest 2008 Venture Showcase Competitio...nvert wastewater from food and beverage companies ...s given top honors out of 22 total entries by a pa...om the sponsoring Colorado law firm of Dorsey &...
...OTTAGE, N.Y., Dec. 8 XTL,Biopharmaceuticals Ltd. ...it is,restructuring its operations following the f...The company is terminating the employment of 9 emp...aining employees will be,responsible for seeking p...,for assisting in the liquidation and/or dispositi...
Other Biology Technology:EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma 2EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma 3EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma 4Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 2Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 3Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 4Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 5
Sheep Anti-Mouse GDF-8 Polyclonal Antibodies, from R&D Systems
Rabbit Anti-SOX10 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Normal Human Serum from 3H Biomedical AB
...d USDA Research Registered OLAW Assured AAALAC Acc... AALAS Certified Technicians Documentation GLP P...equest Focus CRP is your one stop shopping point... offer free project consultation, free peptide seq...
Biology Products: